Nexbrom Eyedrop
Composition
Bromifenac (0.9%)
Superior to Ketorolac in reducing post-operative pain following LASIK or EPI-LASIK.
Posses greater half-life, therefore, needs only "Twice daily application".
Well tolerated and more effective than Dictofenac and Nepafenac in reducing OAF after phacoemulsification.
Better control and better compliance.
Indications
Prevention of Intra-Operative Miosis (In contact Surgery).
Management of Post Lasik Pain and inflammation.
Treatment of CME anterior Uveitis.
The Dependable DUO